금융 뉴스 허브
실시간 글로벌 금융 시장 뉴스 · 분석 · 인사이트
BREAKING주요 뉴스
China's New Five-Year Plan Preps the Nation for Peak Oil
China's energy strategy has largely shielded it from the fallout of the war in Iran and the resultan...
US Stock Indices End Week Lower On Pressure From Elevated Long-Duration Treasury Yields — PSKY, MSTR, WMT, TSLA, NVDA In Focus
The U.S. 30-year Treasury yield climbed for the second straight week....
South Korean Won: Cautious tightening path expected from BoK – DBS
DBS economists Taimur Baig and Radhika Rao expect the Bank of Korea (BoK) to raise its base rate by ...
Sector Update: Energy Stocks Retreat Friday Afternoon
Energy stocks were lower Friday afternoon, with the NYSE Energy Sector Index down 0.7% and the State
Amazon dips as the Blue Origin rocket explosion sets back its global satellite plan
3 Reasons ITW is Risky and 1 Stock to Buy Instead
Illinois Tool Works has been treading water for the past six months, recording a small return of 0.8% while holding steady at $249.49. The stock also fell short of the S&P 500’s 10.3% gain during that ...
BP shares break six-session losing streak
Equity Markets Rise Intraday as Trump Sets Out Conditions For Iran Deal
Equities on Wall Street rose intraday as President Donald Trump laid out conditions that Iran must a
MannKind gains FDA nod to expand inhaled insulin for children
ConocoPhillips shares fall for seven consecutive sessions
Kansas Fed Pres Warns Oil Price Shock Might Not Be Transitory
Federal Reserve Bank of Kansas City President Jeffrey Schmid has warned that the current global energy shock cannot simply be dismissed as transitory, given already-elevated baseline inflation. Speaki ...
3 Healthcare Stocks We Approach with Caution
Healthcare companies are pushing the status quo by innovating in areas like drug development and digital health. Despite the rosy long-term prospects, short-term headwinds such as COVID inventory dest ...
BoE governor warns Middle East ceasefire would ‘still create uncertainty’
Andrew Bailey says rate cuts can only come when policymakers are ‘much more confident’
IBRX Stock Outlook After Q1 Results and a New FDA Review
ImmunityBio eyes a steadier path after a 290% YTD surge as investors watch Anktiva demand, FDA review timing and execution risks.